Impact of a clinical decision support system for drug dosage in patients with renal failure
Sophie Desmedt(Cliniques Universitaires Saint-Luc), Olivia Dalleur(Cliniques Universitaires Saint-Luc), Michel Jadoul(Cliniques Universitaires Saint-Luc), Séverine Henrard(UCLouvain), Dominique Wouters(Cliniques Universitaires Saint-Luc), Anne Spinewine(UCLouvain)
Cited by 37
Related Papers
Chronic kidney disease as a global public health problem: Approaches and initiatives – a position statement from Kidney Disease Improving Global Outcomes
|Kidney International|2007|1.5k
Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
|Kidney International|2020|724
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
|The Lancet|2019|620
Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis
|Journal of the American Society of Nephrology|2017|599
Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference
|Kidney International|2020|548